Background In the present work we study the therapeutic effect of focused ultrasound on localized abscess induced by methicillin-resistant Staphylococcus aureus (MRSA). MRSA is a major nosocomial pathogen in health-care facilities. The people, particularly those who are immunocompromised are prone to develop infectious sites that often are non-responsive to regular treatments. Because of its capability to induce a rise of temperature at a very precise location, the use of focused ultrasound represents a considerable opportunity to propose a new therapy for MRSA-related infections.
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Background In the present work we study the therapeutic effect of focused ultrasound on localized abscess induced by methicillin-resistant Staphylococcus aureus (MRSA). MRSA is a major nosocomial pathogen in health-care facilities. The people, particularly those who are immunocompromised are prone to develop infectious sites that often are non-responsive to regular treatments. Because of its capability to induce a rise of temperature at a very precise location, the use of focused ultrasound represents a considerable opportunity to propose a new therapy for MRSA-related infections.
Methods
A 50µL subcutaneous injection of MRSA strain USA400 bacteria at a concentration of 7x10 3 /µL was made on the left thigh of BALB/c mice and an abscess of 6±2 mm-length formed after 48hrs. A transducer operating at 3 MHz with a focal length of 50mm and diameter of 32mm was used to treat the abscess. The focal point was positioned 2mm under the skin at the abscess center. Forty-eight hours after injection 4 ultrasound exposures of 9s-each were applied to each abscess under Magnetic Resonance-guidance. Each exposure was followed by a 1 min pause. Real-time estimation of change of temperature was done using a communication toolbox (matMRI) developed in our laboratory. Three experimental groups of 6 animals each were tested: moderate temperature (MT), high temperature (HT) and control. MT and HT groups reached, respectively, 55°C and 65°C at end of exposure. Effectiveness of the treatment was assessed by culturing bacteria of the treated abscess 1 and 4 days after treatment. Spleen samples were cultured to test for septicemia. 4 . Absence of bacteria in spleen samples indicated that the therapy did not trigger septicemia.
Results
Macroscopic
Conclusions
Focused ultrasound induces a therapeutic effect in abscesses induced by MRSA. This effect is observed as a reduction of the number bacteria in the abscess. These initial results indicate that focused ultrasound is a viable option for the treatment of MRSA-related infections.
BACKGROUND
Abscesses are confined bacterial infections that involve a localized lesion with an accumulation of pus, surrounded by inflammation [1] . The abscess is formed by an interaction of the immune response of an individual with the bacteria. Abscesses present a fibroblast capsule that surrounds the infection [2] . The initiation and purpose of the capsule is ambiguous but it has been observed that it inhibits the clearance of the bacteria by immune cells and makes it difficult for antibiotics to reach the bacteria. Therefore a treatment success is unlikely if abscesses are exclusively treated with antibiotics and the traditional treatment includes incision and drainage, with or without antibiotic therapy [3] . However, there are delicate or hard accessible areas that would profit from an alternative treatment, not causing scars or requiring extensive surgery. For instance, Hidradenitis suppurativa, an abscess forming disease of groin, axillar and perianal region; abscesses in the perianal region in connection to Crohn's disease; abscesses present in hard to reach regions of the liver, kidney, brain and breast; or skin abscesses caused by Methicilin resistant Staphylococcus aureus (MRSA) which are a growing health concern in hospitalized and chronically ill patients, and are becoming more common in healthy population without the usual risk factors [4] .
High intensity focused ultrasound (HIFU) can be potentially used for the treatment of these localized abscesses. Treatment can be provided by focusing the acoustic waves and inducing localized heating without causing damage to surrounding tissue [5] while the heating can be monitored via magnetic resonance [6] . The use of heat as a tool for disinfection or reduction of bacteria amounts is not new. In the context of safe food handling and storage many studies have been performed showing the vulnerability of S. aureus bacteria strains to heating [7] [8] [9] . Heat has also been proposed as a treatment for skin infections by using pads on the surface of the skin [10] or intra-and perioperative [11] .
In the present work we investigated the effect of focused ultrasound heating on abscesses. We tested the application of focused ultrasound at two different intensities on MRSA subcutaneous abscesses in vivo and evaluated the bacteria growth and abscess healing 1 and 4 days after treatment. We tested the treatment on one of the most common community acquired MRSA strain in Canada that causes skin and soft tissue infections [12] .
METHODS
Thirty-six (36) female BALB/c mice (Balb/cAnNCrl, Charles River, Wilmington, MA, USA), aged 7-12 weeks were used in our study. The mice were housed in microclimate cages (Innovive Inc., San Diego, CA) and received pain medication preand post-treatment with acetaminophen (Mead Johnson & Company, Glenview, IL, USA) and buprenorphine hydrochloride (Schering-Plough, Kenilworth, NJ, USA). The protocol for this study was approved by the Lakehead University Animal Care Committee.
Community-acquired methicillin resistant Staphylococcus aureus, strain USA-400 (C04-8830, pulse field type CMRSA7/ USA 400) was used to induce the abscess in mice. The bacterium was cultivated on tryptic soy agar (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) at 37˚C. The heavy streak of a single colony was transferred into Brain and Heart Infusion Broth (BHI) (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) to cultivate it overnight at 37˚C at 225 rpm. The bacteria suspension was diluted 1:1000 in BHI and cultivated at 37˚C and 225 rpm to mid-exponential growth, at an optical density at 600 nm (OD 600 ) of 0.4. The bacteria suspension was washed 3 times with sterile 0.9% saline and centrifuged at 5000g for 10min. Before filling the syringes for injection, the concentration of the bacteria suspension was adjusted to an OD 600 of 0.03. This was established in preliminary experiments to lead reliably to concentrations around 1.2x10 6 colony forming units (cfu)/mL. This concentration was tested in a preliminary experiment as the ideal amount of bacteria to cause well-sized non-necrotic subcutaneous abscesses.
The mice were anesthetized with isoflurane (Baxter International Inc., Deerfield, IL, USA). The left flank and back was shaved and epilated with Nair ® cream (Church & Dwight Co., Princeton, NJ, USA). The epilated area was disinfected with ethanol and 50µL of bacteria suspension containing 7x10 3 cfu/µL was injected subcutaneously. Forty-eight (48) hours after bacteria injection the animals received the treatment with focused ultrasound.
The animals were placed into a 3T MRI (Achieva, Philips Healthcare) on a focused ultrasound gantry (FUS Instruments, Toronto, Canada). A transducer (TX) operating at 3 MHz with a focal length of 50mm and diameter of 32mm was used to treat the abscess. The focal point was positioned 2mm underneath the skin at the abscess center. MR imaging was performed to visualize the TX and mouse using sagittal and transverse T1 images (GRE, FOV = 120mm×120mm×48 mm, Voxel size = 0.5mm, slice thickness =2mm, TE/TR = 2.5/4.9ms, flip angle = 35°, acquisition matrix = 120×100, reconstruction matrix = 240, 2 NEX). Localization of the abscess was done using coronal T1 images (GRE, FOV = 80mm×80mm×10mm, Voxel size = 0.33mm, slice thickness =0.5mm, TE/TR = 28/56ms, flip angle = 10°, acquisition matrix = 88×87, reconstruction matrix = 240, 4 NEX). Four (4) ultrasound exposures of 9 sec each were applied to each abscess. Exposures were positioned in a square grid of 1 mm × 1 mm and a pause of 1 min was observed between exposures. Real-time estimation of change of temperature was done using a communication toolbox (matMRI) developed in our laboratory [13] using a technique based on water-proton resonance frequency (PRF) [14] . Temperature maps were calculated on a coronal plane using T1 maps (FOV = 80mm, Voxel size = 1mm, slice thickness =3mm, TE/TR = 16/23ms, flip angle = 19°, acquisition matrix = 68×63, reconstruction matrix = 80, ETL=9, 1 NEX). Three experimental groups were treated: moderate temperature (MT) (n=18), high temperature (HT) (n=18) and control (n=18). MT and HT groups reached, respectively, 55°C and 65°C at end of exposure. The control group received no treatment, but underwent the same preparation. The animals of the control group stayed anaesthetized in the MRI for the same duration than the ultrasound treated animals. The animals were sacrificed after day 1 (n=27) and day 4 (n=27). At end point, 4cm 2 of skin around the abscess, the attached abscess, as well as the spleen were removed. Half the skin and half of the abscess were inserted into 10% buffered formalin (Fisher Scientific, Hampton, NH, USA) for fixation. Half the skin plus ¼ of the abscess were weighted and snap frozen in liquid nitrogen for future testing to conduct the Myeloperoxidase (MPO) assay. The other ¼ of the abscess was weighted, added to 150µl sterile 0.9% saline and homogenized on ice with a sterile hand held tissue grinder (Pellet Pestle ® by Kimble-Kontes, Vineland, NJ, USA). The suspension was then included in a dilution series and spread on Tryptic Soy Agar plates. The same procedure was performed with half of the spleen to evaluate the possibility of septicaemia. The plates were cultivated for 24 hours at 37˚C and the single colonies were counted.
Data analysis was performed using SigmaStat 3.5 (Systat Software Inc., San Jose, CA, USA) and the level of significance was determined with p <0.05. The Kruskal-Wallis H test was done for each of both days to compare the two treatment groups and the control group. The Dunn's Method was performed to identify if a group differed from the others.
RESULTS
The procedure was well tolerated by all animals. Scar tissue was observed 24hr after the procedure on the skin region where ultrasound was concentrated. Dissection of animals did not indicate lesions in subcutaneous muscle. No other symptoms of distress were observed. Bacteria counting on days 1 and 4 after procedure are shown in Figure 3 . For the 1-day end point, the counting of bacteria (mean ± s.d.) was 0.7±1.1 x10 5 , 0.5±0.7 x10 5 and 1.1±2.3 x10 5 CFU/µL for MT, HT and control groups, respectively. The difference between groups was no significant. For the 4-day end point, the count was 0.6±0.6 x10 4 , 0.09±0.2x10 4 and 1.0±1.3 x10 4 for MT, HT and control groups, respectively. The difference between HT and the other groups was significant (p<0.05). Absence of bacteria in spleen samples indicated that the therapy did not trigger septicemia.
DISCUSSION AND CONCLUSIONS
HIFU induced a therapeutic effect in abscess that is observed as a reduction of the concentration of MRSA USA-400. The observation that effects were significant 4 days after procedure suggests a more complex process than a simple thermal shock to the bacteria. To establish a relationship of treatment with immune response to the abscess, Neutrophil activity in abscesses will be measured using Myeloperoxiase (MPO) activity and protein assays. Ultrasound parameters of treatment need to be refined to reduce secondary effects on the animal model. Focused ultrasound induces a therapeutic effect in abscesses induced by MRSA. This effect is observed as a reduction of the number bacteria in the abscess. These initial results indicate that focused ultrasound is a viable option for the treatment of MRSArelated infections.
